SDF2 and Insulin resistance: The ASE of SDF2, observed at 70:30 in the hypothalamus and 63:37 in the hippocampus in our study, along with its identification as a pig brain eQTL (Teng et al., 2024), suggests it may help mitigate ER stress, preserve leptin signaling, and reduce inflammation and insulin resistance.